KEGG   DRUG: Denintuzumab mafodotinHelp
Entry
D11232                      Drug                                   

Name
Denintuzumab mafodotin (USAN/INN)
Efficacy
Antineoplastic
Comment
Monoclonal antibody
Treatment of B-cell malignancies
Target
CD19 [HSA:930] [KO:K06465]
TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]
  Pathway
hsa04640  Hematopoietic cell lineage
hsa04662  B cell receptor signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD19
     D11232  Denintuzumab mafodotin (USAN/INN)
 Not elsewhere classified
  Cellular process
   Cytoskeleton
    TUBB
     D11232  Denintuzumab mafodotin (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 1399672-02-6
PubChem: 384585210
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system